A Paradigm Shift in the Treatment of Early-Stage Lung Cancer May Be Leading to More Cures
Instead of waiting until the disease has progressed, researchers have begun analyzing the effects of using immunotherapy before or after surgery in patients with early-stage lung cancer. The results, according to experts, may be transformative for patients.
Follow Your Gut: Advances in Understanding Microbiomes Are Transforming Cancer Care
The gut microbiome plays an important role in how patients may respond to cancer treatments, and researchers are learning more about ways to alter it to benefit treatment outcomes.
Genomic Testing Offers New Therapy Options for Hepatobiliary Cancers
Genomic testing has allowed patients to receive more specific drugs that target mutations in their tumors.
Changing Our Standards
Patients with pancreatic cancer face barriers to clinical trials as a standard of care.
Beyond the Norm
A number of approved therapies can be used to treat pancreatic cancer, but many experts say that clinical trials offer patients greater hope.
'Cracking the Nut' on RAS Mutations
Scientists have spent 35 years seeking ways to disable RAS, a gene that’s mutated in many cancer types. Now, they’re moving closer to solutions.
A Mix-and-Match Approach to Treating Non-Small-Cell Lung Cancer
The combination of immunotherapy and chemotherapy, and more, is changing the landscape of the disease.
Cancer Under Cover
Two schools of thought exist about how to treat metastatic cancers of unidentified subtype, called carcinomas of unknown primary.
Solving a Mystery to Fight a Rare Cancer
An immunotherapy finally gives doctors an approved weapon to fight Merkel cell carcinoma, a rare and still mysterious skin cancer.
Treatment Stages for a Rare Leukemia
THERE ARE THREE STAGES of treatment for acute promyelocytic leukemia: induction therapy, consolidation therapy and maintenance therapy.
Advances Lead to Higher Cure Rate for Rare Leukemia Type
Treatment advances mean high cure rate for patients with APL.
Trying the "Kitchen Sink" to treat Brain Cancer
There are a number of treatment methods being explored to treat glioblastoma.
Hope Comes in Many Forms for Patients With Cancer
For many with glioblastoma, there’s no clear path after standard therapy, but scientists are exploring an array of new options.
Immunotherapy Moves Into Rare Skin Cancer Type
An immunotherapy has become the first of its kind approved to treat Merkel cell carcinoma, a rare and still mysterious skin cancer.
Waiting for the Next Breakthrough: Living With a Chronic Blood Cancer
"Neither feels guilty about surviving — although both have had plenty of reminders that they’re dealing with cancer — and both have found ways to continue enjoying life."
A New Chapter Begins With CML
Hope is growing for patients who are living with CML.
Targeted Power: Improving Prognoses for Patients With Chronic Myeloid Leukemia
Targeted drugs known as TKIs have improved the prognosis for patients with chronic myeloid leukemia.
When Less Is More: Paring Down Treatment for Hodgkin Lymphoma May Reduce the Risk of Long-Term Side Effects
Paring down treatment for Hodgkin lymphoma may reduce the risk of long-term side effects. Minimizing without hurting cure rates is the challenge.
Avoiding the Panic Button: Recovering After Cancer
A wide range of therapies are available to help cancer survivors through recovery, such as meditation, yoga, animal therapy, or art, theater or music therapy.
From Vigilance to Wellness: Striving for Good Overall Health After Cancer
For survivors of cancer, screening intensively for recurrences may be less beneficial than simply striving for good overall health.
On the Fence: The Pros and Cons of Breast Screening
Amid debate about how much screening should be used to detect breast cancer, women at average risk should know the pros and cons.
2 Clarke Drive Cranbury, NJ 08512